Drug Combination Is OKd for Cervical Cancer
- Share via
From Times Wire Reports
A new drug combination to treat women with cervical cancer won federal approval for severe cases when surgery or radiation may not work.
The drug Hycamtin helped patients live about three months longer when used with the chemotherapy agent cisplatin than they lived with cisplatin alone, the Food and Drug Administration said.
Both drugs are already on the market and approved separately to treat other cancers, including ovarian and lung.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
